Trade Mark Journal No.2026/010 6 March 2026

WO0000001902176 (1,5,40)

Office of origin: United States of America

Date of International Registration:30 September 2025
Date of designation in the UK: 30 September 2025
Image for mark 1902176 ONCOPURE

International priority date claimed: 31 March 2025 (United States of America) (99112549)
Class 1
Biological preparations for laboratory, biopharmaceutical processing, and research purposes, namely, reference standards; biological preparations for cancer research; biological preparations for quality control; cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; samples for use in biochemical or biological laboratory analysis for research purposes; cell line-derived products for scientific and research purposes, including for clinical investigations and for use in product testing; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing.
Class 5
Cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing for medical use; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples for medical purposes.
Class 40
Custom manufacture of cell line-delivered products for medical and commercial applications; custom manufacture of reference standards.

Revvity Discovery Limited

Representative: Kevin Oliver Revvity, Inc., 77 4th Avenue, Waltham MA 02451, UNITED STATES OF AMERICA